BE spinout Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal

BE spinout Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal
Tuesday, May 11, 2021

Ginkgo has taken a portfolio approach, working with 70 different customers across diverse industries.